Novel aryl c-xyloside compounds, and cosmetic use
Abstract
The present invention relates to novel compounds of formula (I) where: X is an —OH or ═O grouping; n is an integer between 0 and 5; R′ is H or a C 1 -C 4 alkyl radical, when n≧2, two adjacent —OR′ groupings can together form the divalent radical —O—CH 2 —O—; except when X═OH, the compound does not comprise a double ethylene link in the alpha position of the carbon having said OH. The invention also relates to the salts thereof, to the optical isomers thereof, to the cosmetic and pharmaceutical compositions containing same, and to the use thereof to prevent and cosmetically treat the signs of aging on the skin.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A compound selected from the group consisting of 1-(α,β)-D-xylopyranosyl-4-phenylbutan-2-ol and 1-(α,β)-D-xylopyranosyl-4-(4-hydroxy-3-methoxyphenyl)butan-2-one; and the salts thereof or the solvates thereof.
2 . The compound according to claim 1 being 1-(α,β)-D-xylopyranosyl-4-phenylbutan-2-ol; and the salts thereof or the solvates thereof.
3 . The compound according to claim 1 being 1-(α,β)-D-xylopyranosyl-4-(4-hydroxy-3-methoxyphenyl)butan-2-one; and the salts thereof or the solvates thereof.
4 . A cosmetic or pharmaceutical composition comprising, in a physiologically acceptable medium, at least one compound according to claim 1 .
5 . The cosmetic or pharmaceutical composition according to claim 4 , wherein said compound is 1-(α,β)-D-xylopyranosyl-4-phenylbutan-2-ol; and the salts thereof or the solvates thereof.
6 . The cosmetic or pharmaceutical composition according to claim 4 , wherein said compound is 1-(α,β)-D-xylopyranosyl-4-(4-hydroxy-3-methoxyphenyl)butan-2-one; and the salts thereof or the solvates thereof.
7 . The composition as claimed in claim 4 , in which said compound is present, alone or as a mixture, in an amount of between 0.01% and 10% by weight relative to the total weight of the composition.
8 . The composition as claimed in claim 7 , in said compound is present, alone or as a mixture, in an amount of between 0.1% and 5% by weight.
9 . The composition as claimed in claim 7 , in which said compound is present, alone or as a mixture, in an amount of between 0.5% and 3% by weight.
10 . The composition as claimed in claim 4 , in which the physiologically acceptable medium comprises at least one cosmetic adjuvant chosen from water; organic solvents; hydrocarbon-based oils, silicone oils, fluoro oils, waxes, pigments, fillers, dyes, surfactants, emulsifiers, cosmetic or dermatological active agents, UV-screening agents, film-forming polymers, hydrophilic or lipophilic gelling agents, thickeners, preservatives, fragrances, bactericides, odor absorbers and antioxidants.
11 . The composition as claimed in claim 4 , in which the physiologically acceptable medium comprises at least one compound chosen from: desquamating agents; moisturizing agents; depigmenting or propigmenting agents; anti-glycation agents; NO-synthase inhibitors; agents which stimulate the synthesis of dermal or epidermal macromolecules and/or prevent degradation thereof; agents which stimulate fibroblast and/or keratinocyte proliferation or stimulate keratinocyte differentiation; muscle relaxants and/or dermo-decontracting agents; tensioning agents; anti-pollution agents and/or free-radical scavengers; agents which act on the microcirculation; agents which act on the energy metabolism of cells; and mixtures thereof.
12 . The composition as claimed in claim 4 , which is in the form of an anti-aging, composition intended for combating the external signs of aging of the skin.
13 . A method for nontherapeutic cosmetic treatment of the skin, comprising the application, to the skin, of a cosmetic composition as defined in claim 4 .
14 . A method for nontherapeutic cosmetic treatment of the skin, comprising the application, to the skin, of a cosmetic composition as defined in claim 5 .
15 . A method for nontherapeutic cosmetic treatment of the skin, comprising the application, to the skin, of a cosmetic composition as defined in claim 6 .
16 . The method as claimed in claim 13 , wherein the composition is applied to mature and/or wrinkled skin.
17 . The method as claimed in claim 14 , wherein the composition is applied to mature and/or wrinkled skin.
18 . The method as claimed in claim 15 , wherein the composition is applied to mature and/or wrinkled skin.
19 . The nontherapeutic cosmetic treatment as defined in claim 13 , which comprises improving the firmness of the skin and/or improving the structure of the dermal-epidermal junction and/or reinforcing the cohesion between the dermis and the epidermis.
20 . The nontherapeutic cosmetic treatment as defined in claim 14 , which comprises improving the firmness of the skin and/or improving the structure of the dermal-epidermal junction and/or reinforcing the cohesion between the dermis and the epidermis.
21 . The nontherapeutic cosmetic treatment as defined in claim 15 , which comprises improving the firmness of the skin and/or improving the structure of the dermal-epidermal junction and/or reinforcing the cohesion between the dermis and the epidermis.
22 . The nontherapeutic cosmetic treatment composition as defined in claim 13 , which comprises preventing and/or treating the signs of aging on the skin.
23 . The nontherapeutic cosmetic treatment composition as defined in claim 14 , which comprises preventing and/or treating the signs of aging on the skin.
24 . The nontherapeutic cosmetic treatment composition as defined in claim 15 , which comprises preventing and/or treating the signs of aging on the skin.Join the waitlist — get patent alerts
Track US2014105837A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.